Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, Yang YJ, Zhao Z, Baergen RN, DiPace JI et al.. 2020. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.. BJOG. 127(12):1548-1556. Read more about Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. Google Scholar
Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Prabhu M, Murphy EA, Sukhu AC, Yee J, Singh S, Eng D, Zhao Z, Riley LE, Yang YJ. 2021. Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood.. Obstet Gynecol. 138(2):278-280. Read more about Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Google Scholar
Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates. Kubiak JM, Murphy EA, Yee J, Cagino KA, Friedlander RL, Glynn SM, Matthews KC, Jurkiewicz M, Sukhu AC, Zhao Z et al.. 2021. Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates.. Am J Obstet Gynecol. 225(1):73.e1-73.e7. Read more about Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates. Google Scholar
Epigenetic and transcriptional control of interferon-β. Daman AW, Josefowicz SZ. 2021. Epigenetic and transcriptional control of interferon-β.. J Exp Med. 218(9) Read more about Epigenetic and transcriptional control of interferon-β. Google Scholar
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design. Barone P, DeSimone RA. 2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.. Transfusion. 60(6):1123-1127. Read more about Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design. Google Scholar
Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic. Vossoughi S, Fischkoff K, DeSimone RA, Schwartz J. 2020. Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic.. Transfusion. 60(9):2156-2158. Read more about Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic. Google Scholar
Outcomes associated with SARS-CoV-2 viral clades in COVID-19. Nakamichi K, Shen JZhu, Lee CS, Lee AY, Roberts EAdaline, Simonson PD, Roychoudhury P, Andriesen JG, Randhawa AK, Mathias PC et al.. 2020. Outcomes associated with SARS-CoV-2 viral clades in COVID-19.. medRxiv. Read more about Outcomes associated with SARS-CoV-2 viral clades in COVID-19. Google Scholar
Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19. Nakamichi K, Shen JZ, Lee CS, Lee A, Roberts EA, Simonson PD, Roychoudhury P, Andriesen J, Randhawa AK, Mathias PC et al.. 2021. Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.. Sci Rep. 11(1):4802. Read more about Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19. Google Scholar
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé M et al.. 2021. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.. Trials. 22(1):323. Read more about Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Google Scholar
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R et al.. 2021. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.. Nat Med. Read more about Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Google Scholar